General Information
openpatho Ltd is a private company, limited by shares, registered in England and Wales, under 15261361, at Unit 10 Clayfield Mews, Newcomen Road, Tunbridge Wells, Kent, TN4 9PA. The presentation currency is £ sterling.
| 1. |
Accounting policies
Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard) as well as the Companies Acts.
Going concern basis
The company has continued with the development of its website and App offering and the directors believe that the company will be in a position to see the first sales shortly. In the meantime, the directors consider the company is continues to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The Company's liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted
Intangible assets
Intangible assets (including purchased goodwill and patents) are amortised at rates calculated to write off the assets on a straight line basis over their estimated useful economic lives. Impairment of intangible assets is only reviewed where circumstances indicate that the carrying value of an asset may not be fully recoverable.
Development expenditures
Research and development expenditure is charged to the profit and loss account in the period in which it is incurred. However, where the directors are satisfied as to the technical, commercial and financial viability of individual projects, development expenditure is deferred and amortised over years during which the company is expected to benefit.
Computer software development costs
The Company has undertaken the development of an app and website during the year. The costs of these computer softwares have been capitalised as a detailed program design has been established, and has been amortised over the estimated expected useful economic life of the development of 5 years.
Trademarks
Trademarks are stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the Trademark of 5 years.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
|
| 2. |
Average number of employees
Average number of employees during the year was 2 (2024 : 2).
|
| 3. |
Intangible fixed assets
| Cost |
Other intangible assets |
|
Total |
| |
£ |
|
£ |
| At 01 December 2024 |
27,947 |
|
27,947 |
| Additions |
11,390 |
|
11,390 |
| Disposals |
- |
|
- |
| At 30 November 2025 |
39,337 |
|
39,337 |
| Amortisation |
| At 01 December 2024 |
5,590 |
|
5,590 |
| Charge for year |
7,867 |
|
7,867 |
| On disposals |
- |
|
- |
| At 30 November 2025 |
13,457 |
|
13,457 |
| Net book values |
| At 30 November 2025 |
25,880 |
|
25,880 |
| At 30 November 2024 |
22,357 |
|
22,357 |
|
| 4. |
Tangible fixed assets
| Cost or valuation |
Plant and machinery etc |
|
Total |
| |
£ |
|
£ |
| At 01 December 2024 |
40,300 |
|
40,300 |
| Additions |
2,650 |
|
2,650 |
| Disposals |
- |
|
- |
| At 30 November 2025 |
42,950 |
|
42,950 |
| Depreciation |
| At 01 December 2024 |
8,060 |
|
8,060 |
| Charge for year |
8,590 |
|
8,590 |
| On disposals |
- |
|
- |
| At 30 November 2025 |
16,650 |
|
16,650 |
| Net book values |
| Closing balance as at 30 November 2025 |
26,300 |
|
26,300 |
| Opening balance as at 01 December 2024 |
32,240 |
|
32,240 |
|
| 5. |
Debtors: amounts falling due within one year
|
2025
£ |
|
2024
£ |
| Other Debtors |
2,442 |
|
456 |
|
2,442 |
|
456 |
|
| 6. |
Creditors: amount falling due within one year
|
2025
£ |
|
2024
£ |
| Inviva Ltd |
18,086 |
|
16,309 |
| Other Creditors |
99,284 |
|
61,824 |
|
117,370 |
|
78,133 |
|
| 7. |
Share Capital
Allotted, called up and fully paid
|
2025
£ |
|
2024
£ |
|
100
Class A shares of £1.00 each |
100 |
|
100 |
|
100 |
|
100 |
|
3
|